Caris Molecular Artificial Intelligence™

Caris GPSai™
Caris FOLFIRSTai™

Caris GPSai™

,

Caris GPSai™ analyzes genomic and transcriptomic data to match a tumor’s molecular signature across 21 cancer types from the Caris database to provide additional insight to help oncologists better manage cancers of unknown primary (CUP) or cases with atypical clinical presentation or clinical ambiguity.

Caris FOLFIRSTai™

,

Caris FOLFIRSTai™ is the first clinically validated, AI-powered molecular predictor of chemotherapy efficacy for mCRC patients.

 

Fulfilling the promise of precision medicine

through quality and innovation by individualizing cancer treatments and pioneering a better molecular understanding of cancer.

This experience is designed for larger screens.

To experience this site as intended please make your browser window larger or view it on a tablet, laptop, or desktop screen.

Proceed on smaller screen